Mercury Laboratories Ltd EPS

Mercury Laboratories Ltd EPS

Image

Mercury Laboratories Ltd

NSE: MERCURYLABS

EPS

₹ 36.59

Last updated on: Sep 29, 2026

Key Highlights

  • The Earning per Share of Mercury Laboratories Ltd is ₹ 36.59 as of 29 Sep 26 The earning per share of Mercury Laboratories Ltd changed from ₹ 2.85 to ₹ 2.48 over 9 quarters. This represents a CAGR of -5.99% .

Historical Earning per Share of Mercury Laboratories Ltd

No data available

* All values are in ₹

Company Fundamentals for Mercury Laboratories Ltd

Market Cap

91 Cr

EPS

36.6

P/E Ratio (TTM)

20.8

P/B Ratio (TTM)

1.6

Day’s High

785.0

Day’s Low

750.0

DTE

0.1

ROE

8.3

52 Week High

942.9

52 Week Low

620.55

ROCE

10.8

Market Price of Mercury Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Mercury Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Sep 2026750
29 Sep 2026760
28 Sep 2026784
25 Sep 2026833
24 Sep 2026815.05
23 Sep 2026810
22 Sep 2026817
21 Sep 2026816.55
18 Sep 2026780
16 Sep 2026781

SWOT Analysis Of Mercury Laboratories Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Mercury Laboratories Ltd

Asset Value vs Market Value of Mercury Laboratories Ltd

Market Value

₹ 91

Asset Value

Value addition

1.0 X

₹ 46

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Mercury Laboratories Ltd91.2
Sun Pharmaceutical Industries Ltd446276
Divis Laboratories Ltd251531
Torrent Pharmaceuticals Ltd186957
Zydus Lifesciences Ltd119222
Cipla Ltd111729

Historical Market Cap of Mercury Laboratories Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Mercury Laboratories Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Mercury Laboratories Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Mercury Laboratories Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Mercury Laboratories Ltd News Hub

Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 202

Read more

07 Nov 24

Mercury Laboratories to table results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 202

Read more

07 Feb 25

Mercury Laboratories standalone net profit declines 66.89% in the September 2024 quarter

Net profit of Mercury Laboratories declined 66.89% to Rs 0.50 crore in the quarter ended September 2

Read more

15 Nov 24

Mercury Laboratories to announce Quarterly Result

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 May 2025. Po

Read more

08 May 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Mercury Laboratories Ltd

What is the EPS of Mercury Laboratories Ltd stock?

The Earnings Per Share (EPS) of Mercury Laboratories Ltd is 36.59. An EPS is the amount of net income attributed to each share of a common stock.

How is Mercury Laboratories Ltd EPS calculated?

The EPS of Mercury Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Mercury Laboratories Ltd report its EPS?

Mercury Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Mercury Laboratories Ltd EPS?

Factors that influence the EPS of Mercury Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Mercury Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Mercury Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions